explore -WSS

explore

author：knowledge 2025-08-12 06:44:18 - browse：1

Adam's take main illustration — Molly Ferguson/STAT

Happy Groundhog Day eve. Some takes and thoughts on Bluebird Bio’s quest for gene therapy profits, a reality check on Vertex’s highly touted pain drug, and more ADC investor FOMO.

Bluebird and the case for gene therapy profits

Genetic treatments that are potential cures for inherited diseases are a huge medical advance, but can these transformational (and expensive) products become a profitable business? I’m not sure anyone knows yet for sure, but pay attention to Bluebird Bio over the next year for some clues.

Bluebird is unique among the biotech and pharma companies selling gene therapies (or CRISPR-based medicines) today because it has no other marketed products. With the recent approval of Lyfgenia for sickle cell disease (cost: $3.1 million), Bluebird sells three gene therapies. The other products are Zynteglo for beta thalassemia ($2.8 million) and Skysona for cerebral adrenoleukodystrophy ($3 million). It’s a pure-play commercial gene therapy business. It’s not even trying to develop additional gene therapies currently. R&D expenses are tied to gathering long-term data on its existing products.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： FDA reorg will put new emphasis on investigations, sources say

knowledge

hotspot

WSS

Ventyx halts psoriasis drug development after lackluster trial results

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Healthy food access boosts outcomes in two studies

First transplant of an entire human eye performed

Readout Newsletter: Zepbound, Valneva's vaccine, and more

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

knowledge

explore

Bluebird and the case for gene therapy profits

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ending health disparities requires full federal government, panel says

Sports medicine is finally prioritizing gender equality

Timeline: Special counsel's probe into Trump's handling of classified documents

Wildfire smoke exposes gaps in outdoor worker protections

Interest rates are at a 22

In Memoriam: Notable people who died in 2023

Today's health inequities arise from racist U.S. history, say experts

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Weight loss drugs should be covered by insurers, AMA says

explore

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

CVS, Rite Aid closures threaten to worsen pharmacy deserts

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Public health communication lessons from Covid

explore

knowledge

hotspot

knowledge